checkAd
    Startseite > Aktien > Acrivon Therapeutics > Nachrichten
    Acrivon Therapeutics Aktie
    8,7550
     
    USD
    +2,28 %
    +0,1950 USD
    Letzter Kurs 19:40:55 Nasdaq
    8,7000
     
    USD
    100 STK
    Geldkurs 19:41:41
    8,8000
     
    USD
    2.900 STK
    Briefkurs 19:41:41
    ISIN: US0048901096 · WKN: A3DXE7 · SYM: ACRV · USA

    Neueste Nachrichten

    Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
    14.05.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
    24.04.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
    17.04.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistan
    10.04.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Announces $130 Million Private Placement Financing
    09.04.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
    28.03.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316
    05.03.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors
    04.03.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference
    27.02.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors
    08.02.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    06.02.24 · globenewswire · Acrivon Therapeutics
    Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    12.01.24 · globenewswire · Acrivon Therapeutics